Clinical trial results of Pfizer/BioNTech’s Covid-19 vaccine showed its efficacy…


Clinical trial results of Pfizer/BioNTech’s Covid-19 vaccine showed its efficacy is 100% and it is well tolerated in youths ages 12 to 15, the companies said Wednesday. The vaccine is currently authorized in the US for emergency use in people 16 and older. “The bottom line is that by the fall I think there’s a good possibility we’ll be vaccinating teenagers, 12 and up,” said Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, noting that the vaccine will still need to be evaluated for authorization in that age group. ⁠

(📸: Antonio Masiello/Getty Images)⁠



Credit to the Original Source

(Visited 2 times, 1 visits today)

About The Author

You might be interested in

Comment (13)

  1. ‪I wish i didnt have to do this but this all i have right now , ima 16 year old rapper from Florida 🐊i dropped outta school to chase my dream , it would be a blessing if somebody check out and give feedback on my newest song THANK YOU 🙏🏾❤️

  2. 𝑰𝒕’𝒔 𝒃𝒆𝒆𝒏 𝒂 𝒑𝒐𝒔𝒊𝒕𝒊𝒗𝒆 𝒐𝒖𝒕𝒄𝒐𝒎𝒆 𝒂𝒍𝒍 𝒕𝒉𝒓𝒐𝒖𝒈𝒉𝒐𝒖𝒕 𝒎𝒚 𝒊𝒏𝒗𝒆𝒔𝒕𝒎𝒆𝒏𝒕 𝒑𝒆𝒓𝒊𝒐𝒅 𝒘𝒊𝒕𝒉 @luiz__braydenfx i 𝒎𝒂𝒅𝒆 𝒐𝒗𝒆𝒓 $24,000 investing $1500 in a week 😊🥺

  3. I was vaccinated 2 months ago, how long does it last and if you don’t know when should i get a booster???????

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *